Navigation Links
New monoclonal antibody developed that can target proteins inside cancer cells
Date:3/13/2013

NEW YORK, MARCH 13, 2013 Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells. Scientists from Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.

Unlike other human therapeutic monoclonal antibodies, which can target only proteins that remain on the outside of cancer cells, the new monoclonal antibody, called ESK1, targets a protein that resides on the inside of the cell.

ESK1 is directed at a protein called WT1, which is overexpressed in a range of leukemias and other cancers including myeloma and breast, ovarian, and colorectal cancers. WT1 is a high priority target for cancer drugs because it is an oncogenic protein, meaning that it supports the formation of cancer. In addition, it is found in few healthy cells, so there are less likely to be side effects from drugs that target it.

"This is a new approach for attacking WT1, an important cancer target, with an antibody therapy. This is something that was previously not possible," said David A. Scheinberg, MD, PhD, Chair of the Sloan-Kettering Institute's Molecular Pharmacology and Chemistry Program and an inventor of the antibody. "There has not been a way to make small molecule drugs that can inhibit WT1 function. Our research shows that you can use a monoclonal antibody to recognize a cancer-associated protein inside a cell, and it will destroy the cell."

The first studies of the antibody are showing promise in preclinical research as a treatment for leukemia as reported March 13, 2013, in Science Translational Medicine.

"ESK1 represents a paradigm change for the field of h
'/>"/>

Contact: Caitlin Hool
hoolc@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Clinical trial for rabies monoclonal antibody
2. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
3. Flu antibody’s one-handed grab may boost effort toward universal vaccine, new therapies
4. Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
5. Flu breakthrough: New drug developed to combat flu pandemic
6. University-developed omega-3-rich ground beef available soon
7. How the protein transport machinery in the chloroplasts of higher plants developed
8. High Brightness Tetrapod Quantum Dots Developed
9. Test developed to detect early-stage diseases with naked eye
10. New cranial neural crest cell line developed
11. Humanized mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... of Calgary,s Faculty of Medicine have discovered a mechanism ... bacteria. Platelets, a component of blood typically associated with ... and upon detection, seal it off from the rest ... Nature Immunology this week, provide the science ... science community has known that platelets do participate in ...
(Date:6/18/2013)... a hacker lab. At Brandeis University, sophisticated computational ... helping scientists understand the complex interplay between genomic ... virus, outer "shell" critical for replication. ... we are finding will help researchers alter virus ... fellow Jason Perlmutter, first author of the scientific ...
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... led by the University of Minnesota, addressing long-standing ... key directions for the future of community ecology. ... applies knowledge of evolutionary relationships among different species ... and biodiversity. The work, published in the ...
... study of pollutants in marine mammals, brains reveals that ... pesticides such as DDTs and PCBs, as well as ... Eric Montie, the lead author on the study currently ... Environmental Pollution , performed the research as a student ...
... The National Institutes of Health is launching the ... treatments for rare and neglected diseases. The $24 ... Therapeutics for Rare and Neglected Diseases Program, or ... this spring, is unusual because TRND creates a ...
Cached Biology News:U of Minnesota research reveals critical role of evolutionary processes in species coexistence 2Skip this cocktail party 2Skip this cocktail party 3NIH announces new program to develop therapeutics for rare and neglected diseases 2NIH announces new program to develop therapeutics for rare and neglected diseases 3NIH announces new program to develop therapeutics for rare and neglected diseases 4NIH announces new program to develop therapeutics for rare and neglected diseases 5
(Date:6/20/2013)... , June 20, 2013 Based ... market, Frost & Sullivan presents bitop AG with ... New Product Innovation. The company,s path-breaking extremolyte platform ... rhinitis and conjunctivitis, dry eye or dry nose ... line is expected to revolutionize how allergies are ...
(Date:6/20/2013)... Over the years, GLM Displays , ... questions that can be summed up in one simple question, ... GLM Displays, Matt Lunser, sat down and put together a ... and offer some useful tips on how to maximize ROI ... guide is meant to help our clients understand some of ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Belatrix Software, ... , today released news on its latest initiative – ... initiative brings together leading thought leaders, and business and ... and dynamic workshops. The goal of the initiative is ... gain fresh inspiration for their product innovation efforts. ...
(Date:6/20/2013)... 20, 2013 Many health benefits have ... according to Sturgeon Bay, Wisconsin Chiropractor and ... . Recent research has been looking into the ... disease. , Researcher Janice Kiecolt-Glaser and her team at ... have studied the health benefits of Omega-3s for years. ...
Breaking Biology Technology:Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 2Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 3Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 4Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2Omega-3 Fatty Acids: the Fountain of Youth? 2Omega-3 Fatty Acids: the Fountain of Youth? 3Omega-3 Fatty Acids: the Fountain of Youth? 4
... shares of Common Stock in Exchange, for Senior Subordinated and ... ... interest, SEATTLE, Feb. 13 Cell Therapeutics, Inc.,("CTI" or the ... in aggregate principal of its outstanding 5.75%,Convertible Senior Subordinated Notes due 2008 ...
... (Nasdaq:,CEPH) issued the following statement in response to ... Commission (FTC) in U.S. District Court for the,District ... entered,into by the company in late 2005 and ... infringement litigation and seeking to,permanently enjoin the Company ...
... Board Authority to Implement Reverse Stock Split and ... Shares and Authorized Shares, NEW HAVEN, Conn., Feb. 13 ... Special Meeting of,Stockholders was held at the Omni Hotel in ... meeting, shareholders voted to approve amendments to the,Company,s Restated Certificate ...
Cached Biology Technology:Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008 2Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements 2Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements 3Vion Pharmaceuticals Holds Special Meeting of Stockholders 2Vion Pharmaceuticals Holds Special Meeting of Stockholders 3
Shotgun library construction and high-throughput DNA sequencing of microbial genomes, BACs, adenoviruses, phosmids and cosmids. LIMS tracking utilizing Geospiza's Finch system....
... XAB2 (amino terminus) XAB2 (XPA-binding protein ... with XPA. Immunoprecipitation experiments have also demonstrated ... the transcription-coupled repair-specific proteins CSA and CSB ... Microinjection experiments with XAB2 antibodies resulted in ...
...
A component of the Acridinium protein labeling kit....
Biology Products: